Access to hepatitis C virus treatment: Lessons from implementation of strategies for increasing access to antiretroviral treatment
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 70, 65-68
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?Globalization and Health, 2017
- Financing the HIV response in sub-Saharan Africa from domestic sources: Moving beyond a normative approachSocial Science & Medicine, 2016
- Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic AnalysisPLOS Medicine, 2016
- Global epidemiology and genotype distribution of the hepatitis C virus infectionJournal of Hepatology, 2014
- Driving a decade of change: HIV/AIDS, patents and access to medicines for allJournal of the International AIDS Society, 2011
- The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsThe Lancet, 2006
- The fight against stigma: An overview of stigma-reduction strategies and interventionsPsychology, Health & Medicine, 2006